Search

everythinglearnresearchcommunity

for

Search:↓

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Monitoring for adverse effects in clinical treatments is crucial.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Stress and hormones like progesterone can affect absence seizures, but their effects change with different life stages.

Spironolactone can cause side effects like irregular bleeding, but lower doses may reduce these effects and still improve hirsutism.

Cats with Feline Symmetrical Alopecia can regrow hair with proper treatment based on the specific cause, including diet, medication, or stress management.

A mix of Polygonatum sibiricum and Nelumbinis semen may ease menopause symptoms with fewer side effects.

Localized estrogen treatments may improve skin quality with fewer risks than systemic hormone therapy.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Progesterone reduces anxiety and depression in female mice by increasing BDNF in the brain, needing 5α-reduction and estradiol.